Replies to post #124057 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Question whether 273 for MS can be done as a separate deal with Biogen...or will it have to be a deal for 273 in all applications?

I would think Dr. M would prefer to just do an MS deal with Biogen, maybe partnering 273 with their MS drugs in a combo treatment. That would provide enough cash to keep going, say $50m upfront, and allow for an enormous payday on approval for alz, maybe in deal with Pfizer.

But not sure if there would be issues of each trying to sell into the other's market.

Maybe pricing would be different for alz and MS markets.